Successful Treatment of Elbow Tumor Using Electrochemotherapy: A Case Study

Successful Treatment of Elbow Tumor Using Electrochemotherapy: A Case Study

Successful Treatment of Elbow Tumor Using Electrochemotherapy

Medical professionals often face significant challenges when treating complex and rare conditions. Among these, bone and soft tissue tumors present particular difficulties, sometimes leaving amputation as the only viable option. This report details the case of a 27-year-old female patient with a persistent right elbow tumor who, after years of unsuccessful treatments, achieved remarkable results through electrochemotherapy.

The Challenge of Treating Bone and Soft Tissue Tumors
Conventional treatments for bone and soft tissue tumors don’t always yield positive outcomes. In cases where standard therapies fail, minimally invasive approaches like electrochemotherapy can serve as effective alternatives. For this patient, the method not only alleviated pain and restored mobility but also prevented the need for amputation.

Electrochemotherapy, combined with electrical currents and localized chemotherapy, directly targets tumors while minimizing side effects. This approach is particularly valuable for patients unresponsive to traditional treatments or those ineligible for surgery. Below, we present a successful case treated with the Pars Tarava electrochemotherapy device.

Patient History


The patient, a 27-year-old woman, had been suffering from a right elbow tumor since the age of 13. The growth caused severe pain and significantly restricted elbow movement. Over the years, she underwent multiple treatments, none of which provided substantial relief. Before considering electrochemotherapy, her medical team recommended amputation—a suggestion she refused due to its psychological and physical repercussions.

Initial Consultation


The patient sought treatment due to debilitating pain and complete loss of elbow mobility. After a thorough examination and diagnostic tests, the medical team opted for electrochemotherapy—a minimally invasive yet effective approach for bone and soft tissue tumors.

Treatment Sessions


The patient underwent four electrochemotherapy sessions using the Pars Tarava device on the following dates:

Each session involved controlled electrical currents and localized chemotherapy injections directly into the tumor.

Session 1


At the first session, the patient reported severe pain and complete immobility. Post-treatment, she noted slight pain reduction but no significant improvement in movement.

Session 2


By the second session, mobility had improved—she could move her arm 20-30 degrees. This progress indicated the treatment’s positive effect on the tumor and the surrounding tissues.

Session 3


During the third session, the patient reported substantial pain relief and increased range of motion. The treating physician observed noticeable tumor shrinkage.

Session 4


Further improvements in mobility and pain reduction were noted at the final session. The physician also observed changes in tumor secretions, signaling a positive therapeutic response.

Treatment Outcomes


Following four electrochemotherapy sessions:

Conclusion


This successful treatment highlights electrochemotherapy’s potential for bone and soft tissue tumors. Not only did it restore function and reduce pain, but it also spared the patient from amputation. Given these results, electrochemotherapy should be considered a viable option for similar cases.

Recommendations

As medical technology advances, we hope to offer even more effective, minimally invasive treatments to improve patients’ quality of life.

For consultation requests, purchasing information, or clinical support:

📞 +98 902 405 1862 (Tehran Office)
📧 info@persiantarava.me

Office Hours: Saturday-Wednesday 9:00 AM to 4:00 PM IRST

Tagged